Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.745
-0.065 (-3.59%)
Aug 28, 2026, 12:04 PM EDT - Market open
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $74.35 million as of August 28, 2026. Its market cap has increased by 62.36% in one year.
Market Cap
74.35M
Enterprise Value
55.62M
1-Year Change
62.36%
Ranking
Category
Stock Price
$1.75
ChartMarket Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $74.35M, an increase of 18.94%. That is a compound annual growth rate of 2.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 74.35M | -18.92% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 81.84M |
| OKYO Pharma | 81.34M |
| Gain Therapeutics | 80.74M |
| Alterity Therapeutics | 79.79M |
| Cingulate | 79.11M |
| Dogwood Therapeutics | 78.86M |
| Elicio Therapeutics | 78.85M |
| OS Therapies | 77.49M |